Can herbs provide a new generation of drugs for treating Alzheimer's disease?

Thimmappa S. Anekonda, P. Hemachandra Reddy

    Research output: Contribution to journalReview article

    112 Scopus citations

    Abstract

    The overall aim of this review is to discuss cellular mechanisms at work in the progression of AD and current therapeutic strategies for treating AD, with a focus on the potential efficacy of herbal treatments. Recent advances in molecular, cellular, and animal model studies have revealed that formation of the 4-kDa amyloid beta peptide is a key factor in the development and progression of AD. Several cellular changes have been identified that are related to amyloid beta plaques and neurofibrillary tangles found in the autopsied brains of AD patients and in AD animal models. Several therapeutic strategies have been developed to treat AD, including anti-inflammatory, anti-oxidant, and anti-amyloid approaches. Recently, herbal treatments have been tested in animal and cellular models of AD and in clinical trials with AD subjects. In AD animal models and cell models, herbal extracts appear to have fewer adverse effects than beneficial effects on Aβ and cognitive functions. These extracts have multi-functional properties (pro-cholinergic, anti-oxidant, anti-amyloid, and anti-inflammatory), and their use in the treatment of AD patients looks promising. The chemical compositions of herbs and their potential for alleviating or reducing symptoms of AD or for affecting the disease mechanism need to be further studied.

    Original languageEnglish (US)
    Pages (from-to)361-376
    Number of pages16
    JournalBrain Research Reviews
    Volume50
    Issue number2
    DOIs
    StatePublished - Dec 15 2005

    Keywords

    • Alzheimer's disease
    • Animal model
    • Bioavailability
    • Herbal drug
    • In vitro model
    • Mitochondria

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Clinical Neurology

    Fingerprint Dive into the research topics of 'Can herbs provide a new generation of drugs for treating Alzheimer's disease?'. Together they form a unique fingerprint.

  • Cite this